We are live on
!
Find out more
DCM
DAFNA Capital Management Portfolio holdings
AUM
$440M
1-Year Est. Return
109.12%
This Fund
S&P 500
This Quarter
Est. Return
+19.23%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$140M
AUM Growth
+$21.9M
(+19%)
Cap. Flow
+$4.55M
Cap. Flow
% of AUM
3.25%
Top 10 Holdings %
Top 10 Hldgs %
48%
Holding
83
New
9
Increased
22
Reduced
16
Closed
8
Top Buys
| 1 |
AERI
Aerie Pharmaceuticals
AERI
|
+$2.79M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
+$2.7M |
| 3 |
DERM
Dermira, Inc.
DERM
|
+$1.44M |
| 4 |
SGMO
SANGAMO THERAPEUTICS INC
SGMO
|
+$1.44M |
| 5 |
Minerva Neurosciences
NERV
|
+$1.42M |
Top Sells
| 1 |
AtriCure
ATRC
|
+$2.61M |
| 2 |
TVRD
Tvardi Therapeutics
TVRD
|
+$1.75M |
| 3 |
NVDQ
Novadaq Technologies Inc.
NVDQ
|
+$747K |
| 4 |
MTVA
MetaVia Inc
MTVA
|
+$725K |
| 5 |
Abeona Therapeutics
ABEO
|
+$338K |
Sector Composition
| 1 | Healthcare | 80.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LOXO
1
DELISTED
Loxo Oncology, Inc
LOXO
| $24.3M | 17.37% |
303,621
+2,899
| +1% | +$161K |
|
|
2
AtriCure
ATRC
$1.75B
| $9.32M | 6.65% |
384,145
-122,801
| -24% | -$2.61M |
|
|
IMMU
3
DELISTED
Immunomedics Inc
IMMU
| $5.63M | 4.02% |
637,700
+385,126
| +152% | +$2.7M |
|
|
AERI
4
DELISTED
Aerie Pharmaceuticals
AERI
| $5.61M | 4% |
106,770
+60,000
| +128% | +$2.79M |
|
|
NXTM
5
DELISTED
NxStage Medical Inc.
NXTM
| $5.42M | 3.87% |
216,119
| – | – |
|
|
BPMC
6
DELISTED
Blueprint Medicines
BPMC
| $4.16M | 2.96% |
82,000
-500
| -0.6% | -$21.2K |
|
7
BioCryst Pharmaceuticals
BCRX
$2.41B
| $3.29M | 2.35% |
591,128
+50,000
| +9% | +$305K |
|
|
ONC
8
BeOne Medicines Ltd
ONC
$32.3B
| $3.29M | 2.35% |
73,036
-8,195
| -10% | -$323K |
|
9
Insulet
PODD
$11.2B
| $3.26M | 2.32% |
63,484
| – | – |
|
|
LKFT
10
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.94B
| $2.95M | 2.11% |
38,609
+3,250
| +9% | +$273K |
|
11
iShares Biotechnology ETF
IBB
$9.23B
| $2.7M | 1.93% |
26,100
| – | – |
|
|
ALDR
12
DELISTED
Alder Biopharmaceuticals
ALDR
| $2.53M | 1.81% |
221,013
| – | – |
|
|
BEAT
13
DELISTED
BioTelemetry, Inc.
BEAT
| $2.51M | 1.79% |
75,000
| – | – |
|
14
Neurocrine Biosciences
NBIX
$17.2B
| $2.51M | 1.79% |
54,508
-4,000
| -7% | -$194K |
|
|
15
Minerva Neurosciences
NERV
$201M
| $2.44M | 1.74% |
34,540
+21,875
| +173% | +$1.42M |
|
|
RDUS
16
DELISTED
Radius Health, Inc.
RDUS
| $2.41M | 1.72% |
53,309
+4,500
| +9% | +$172K |
|
|
VIRX
17
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $2.3M | 1.64% |
24,295
-492
| -2% | -$56.5K |
|
|
DERM
18
DELISTED
Dermira, Inc.
DERM
| $2.2M | 1.57% |
75,500
+47,500
| +170% | +$1.44M |
|
|
AGTC
19
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $2.15M | 1.53% |
421,000
+10,000
| +2% | +$56.2K |
|
|
SPNC
20
DELISTED
Spectranetics Corp
SPNC
| $2.15M | 1.53% |
55,896
-9,600
| -15% | -$277K |
|
21
MacroGenics
MGNX
$271M
| $2.09M | 1.49% |
119,200
| – | – |
|
|
SGMO
22
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.98M | 1.41% |
+225,000
| New | +$1.44M |
|
|
CLLS
23
Cellectis
CLLS
$282M
| $1.97M | 1.41% |
76,404
| – | – |
|
24
Akebia Therapeutics
AKBA
$365M
| $1.95M | 1.39% |
135,738
+65,283
| +93% | +$827K |
|
25
Ardelyx
ARDX
$1.29B
| $1.9M | 1.36% |
373,409
+151,671
| +68% | +$1.29M |
|
Similar funds
FGWP
STCG
SCP
CAAM
AWM
HCM
CPW
DWML